Allosteric modulation company Addex Therapeutics Ltd announced that it has launched a CHF 40 m capital increase with commitments in place from several world-leading healthcare investors,…
Addex Therapeutics Ltd’s CHF 40 million capital increase
Allosteric modulation company Addex Therapeutics Ltd announced that it has launched a CHF 40 m capital increase with commitments in place from several world-leading healthcare investors,…